Wearable patch monitors heart failure patients

Researchers have developed a wearable patch capable of tracking cardiac activity and examining the user's heart failure status.

Remote patient monitoring in those with compensated and decompensated heart failure is not a usual practice but could reduce hospital readmission and mortality rates. The patch has the basic abilities of an echocardiogram and seismocardiogram.

“Wearable technologies recording cardiac function and machine learning algorithms can assess compensated and decompensated HF states by analyzing cardiac response to submaximal exercise,” wrote lead study author Omer T. Inan, PhD. “These techniques can be tested in the future to track the clinical status of outpatients with HF and their response to pharmacological interventions.”

Read the story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.